AzTrials
AzTrials

Intravascular VolumeNCT03673475

Internal Jugular Vein Distensibility and Pleth Variability Index(PVI) for Evaluating Fluid Responsiveness

An observational study of Intravascular Volume, run by Tepecik Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Assessment of intravascular volume status is crucial in order to predict the efficacy of volume status in major abdominal surgery. The aim of the study is to verify the feasibility and usefulness of the internal jugular vein distensibility index as an adjunct to the pleth variebility index(PVI) to predict fluid… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intravascular Volume
What is being tested?
Assessment of fluid responsiveness
Type of treatment
Surgery or procedure
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2018to 30 Sep 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients undergoing major abdominal surgery

Who may be able to join

  • American Society of Anesthesiologists(ASA) physical status I-III patients
  • patients undergoing major abdominal surgery

Who cannot join

  • arrythmia
  • severe right ventricle failure

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Tepecik Training and Research Hospital

    Izmir

Other trials in Turkey (Türkiye)

About this study

Official title: Internal Jugular Vein Distensibility and Pleth Variability Index for Evaluating Fluid Responsiveness

Assessment of intravascular volume status is crucial in order to predict the efficacy of volume status in major abdominal surgery. The aim of the study is to verify the feasibility and usefulness of the internal jugular vein distensibility index as an adjunct to the pleth variebility index(PVI) to predict fluid responsiveness in major abdominal surgery.

Read the detailed description

Forty patients above age 18 and ASA status I-III who are undergoing major abdominal surgery will be enrolled in the study. patients with right heart failure, arrythmia, severe valve stenosis or regurgitation will be excluded. After induction of general anesthesia, when the patients are hemodynamically stabilised, PVI and jugular vein distensibility will be calculated and recorded. after volume load with 500 ml gel infusion(in 15 min), measurements will be repeated within 10 minutes and recorded. Patients will be allocated to 2 groups according to the change in mean arterial pressure(MAP) after volume expansion: Responders will be defined as an increase in MAP by >%10; while nonresponders will be defined as an increase in MAP <%10 or decrease in MAP.

Being tested
Assessment of fluid responsiveness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment of fluid responsivenessProcedure or surgery

    assessment of intravascular volume status using pleth variebility index and internal jugular vein distensibility in major abdominal surgery

Study groups in NCT03673475
Study groupRoleWhat they receive
fluid responsivenessAssessment of fluid responsiveness using pleth variebility index and jugular vein distensibility in patients undergoing major abdominal surgery
Receives: Procedure: Assessment of fluid responsiveness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. number of patients with significant change in VJI distensibility and pleth variebility index

    volume responders with significant change in jugular vein distensibility and pleth variebility index

    Measured: during surgery at day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2018
  2. Study start1 Feb 2018
  3. Primary completion30 Sep 2018
  4. Study completion30 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03673475
Sponsor's protocol ID
Meltem Cakmak
Status last verified
Nov 2018
First submitted
24 Aug 2018
Last updated
27 Nov 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intravascular Volume, run by Tepecik Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

number of patients with significant change in VJI distensibility and pleth variebility index (time frame: during surgery at day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in